Bruselix Gel 38.8 mg/g
Lidocaine HCI 3.88% · GEL · PureTek Corporation
Bruselix Gel is a gel containing lidocaine hci 3.88% at 38.8 mg/g, taken topical. Manufactured by PureTek Corporation.
Key Facts
- Brand Name
- Bruselix Gel
- Generic Name
- Lidocaine HCI 3.88%
- NDC Code (Product)
59088-233- Manufacturer
- PureTek Corporation
- Strength
- 38.8 mg/g
- Dosage Form
- GEL
- Route
- TOPICAL
- Marketing Status
- Marketing Start
- 03/21/2024
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
INDICATIONS: For the temporary relief of pain.
Dosage & Administration
DOSAGE: Apply a thin film to the affected area two or three times daily or as directed by a licensed healthcare practitioner.
Warnings
WARNINGS: For external use only. Not for ophthalmic use.
Contraindications
CONTRAINDICATIONS: Tuberculous or fungal lesions of skin vaccinia, varicella and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
Adverse Reactions
ADVERSE REACTIONS: During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.
Frequently Asked Questions
What is Bruselix Gel used for?
Bruselix Gel contains Lidocaine HCI 3.88%. It is a gel taken topical. Consult your doctor for specific uses.
Is Bruselix Gel a controlled substance?
Bruselix Gel is not classified as a controlled substance by the DEA.
What is the generic name for Bruselix Gel?
The generic name for Bruselix Gel is Lidocaine HCI 3.88%. There are 1 other brand versions of Lidocaine HCI 3.88%.
What is the NDC code for Bruselix Gel 38.8 mg/g?
The NDC (National Drug Code) for Bruselix Gel 38.8 mg/g is 59088-233, listed by PureTek Corporation.